Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 1;10(18):18213-18224.
doi: 10.1021/acsomega.4c03612. eCollection 2025 May 13.

Microwave-Fluidic Continuous Manufacturing of Ultrasmall Silver Nanoparticles in a Polycaprolactone Matrix as Antibacterial Coatings

Mona Nejatpour  1 , Oğuz Bayındır  1 , Pelin Duru  2 , Milad Torabfam  2 , Cem Meriç  2 , Hasan Kurt  3   4   5 , Meral Yüce  1   2 , Mustafa Kemal Bayazıt  1   2
Affiliations

Microwave-Fluidic Continuous Manufacturing of Ultrasmall Silver Nanoparticles in a Polycaprolactone Matrix as Antibacterial Coatings

Mona Nejatpour et al. ACS Omega. .

Abstract

Fast, energy-efficient, and continuous manufacturing of nanoparticles (NPs) with controlled size and distribution in polymer matrices is challenging. Herein, a microwave-powered dual-injection continuous flow reactor is presented to prepare silver NP (AgNP)/polycaprolactone (PCL) nanocomposites (AgNP/PCL NCs). Ultrasmall spherical AgNPs (US-AgNPs, 1.86 ± 0.77 nm) can be manufactured in the PCL matrix in less than 3 min at ∼35 °C by applying 60 W microwave power and a combined flow rate of 1.25:1.25 mL/min (Pump1:Pump2). The effect of NP size and amount on the thermal, optical, and antimicrobial properties and the crystallinity of NCs are discussed. The NC crystallinity is independent of the NP's size and amount, while the NC film roughness is highly dependent on NP size. The antibacterial activity of the US-AgNPs-containing NC toward Escherichia coli (∼98.2%), Pseudomonas aeruginosa (∼98.2%), and Staphylococcus aureus (∼99.1%) is higher than big AgNP-containing NCs (82.3%, 85.7%, and 92.3%, respectively), signifying a strong NP size dependency instead of Ag concentration.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following competing financial interest(s): Patent pending (TR2021/011988, PCT/TR2022/050465) on the approach to manufacturing high-efficiency antimicrobial NCs reported herein continuously.

Figures

Figure 1
Figure 1
Illustration of a double-pump continuous MWFS to prepare NCs.
Figure 2
Figure 2
Effect of MW power. a) Photographs of as-prepared NC1–6 solutions, b) UV–vis spectra, and c) particle size analysis (by DLS) of NC1–6.
Figure 3
Figure 3
Effect of flow rate. a) Photographs of as-prepared NC7–11 solutions, b) UV–vis spectra, and c) particle size analysis (by DLS) of NC7–11.
Figure 4
Figure 4
Effect of AgNO3 and PCL concentrations. a) Photographs of as-prepared NC12–16 solutions, b) UV–vis spectra, and c) particle size analysis (by DLS) of NC12–16.
Figure 5
Figure 5
TEM images of NC8 (a, b) and NC11 (d, e) at different magnifications and the mean particle size distribution of AgNPs in NC8 (c) and NC11 (f).
Figure 6
Figure 6
a) FTIR, b) TGA-DTA, and c) XRD results of PCL, NC8, and NC11. Inset in b shows the DTA vs temperature plot. Insets in c display the enlarged regions of corresponding PCL (black), NC8 (red), and NC11 (NC11). The labels correspond to the observed peak positions and diffraction planes.
Figure 7
Figure 7
Colony-forming units (CFU) of E. coli, S. aureus, and P. aeruginosa after exposure to uncoated glass and PCL, NC8, and NC11 films.
See this image and copyright information in PMC

References

    1. Huh A. J.; Kwon Y. J. ″Nanoantibiotics″: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J. Controlled Release 2011, 156 (2), 128–145. 10.1016/j.jconrel.2011.07.002. - DOI - PubMed
    1. Tran P. A.; Hocking D. M.; O’Connor A. J. In situ formation of antimicrobial silver nanoparticles and the impregnation of hydrophobic polycaprolactone matrix for antimicrobial medical device applications. Mater. Sci. Eng. C Mater. Biol. Appl. 2015, 47, 63–69. 10.1016/j.msec.2014.11.016. - DOI - PubMed
    1. Neal A. L. What can be inferred from bacterium-nanoparticle interactions about the potential consequences of environmental exposure to nanoparticles?. Ecotoxicology 2008, 17 (5), 362–371. 10.1007/s10646-008-0217-x. - DOI - PubMed
    1. Karwowska E. Antibacterial potential of nanocomposite-based materials – a short review. Nanotechnol. Rev. 2017, 6 (2), 243–254. 10.1515/ntrev-2016-0046. - DOI
    1. Duncan T. V. Applications of nanotechnology in food packaging and food safety: barrier materials, antimicrobials and sensors. J. Colloid Interface Sci. 2011, 363 (1), 1–24. 10.1016/j.jcis.2011.07.017. - DOI - PMC - PubMed

LinkOut - more resources